{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:26:43Z","timestamp":1792628803892,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-16-1-0321"],"award-info":[{"award-number":["W81XWH-16-1-0321"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00213-023-06452-1","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T23:24:46Z","timestamp":1702423486000},"page":"19-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder"],"prefix":"10.1007","volume":"241","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-0634","authenticated-orcid":false,"given":"David Q.","family":"Beversdorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Bellesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy U.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Muckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Selders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Holem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Sohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Stichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Mazurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"6452_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/00001756-199909090-00012","volume":"19","author":"JK Alexander","year":"2007","unstructured":"Alexander JK, Hillier A, Smith RM, Tivarus ME, Beversdorf DQ (2007) Noradrenergic modulation of cognitive flexibility during stress. J Cogn Neurosci 19:468\u2013478. https:\/\/doi.org\/10.1097\/00001756-199909090-00012","journal-title":"J Cogn Neurosci"},{"key":"6452_CR2","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Fields CJ (1985) The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Mental Defic 89:485\u2013491","journal-title":"Am J Mental Defic"},{"key":"6452_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V)","author":"American Psychological Association","year":"2013","unstructured":"American Psychological Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V). American Psychological Association, Washington, DC. https:\/\/doi.org\/10.1176\/appi.books.9780890425596"},{"key":"6452_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/BF02211876","volume":"18","author":"C Barthelemy","year":"1988","unstructured":"Barthelemy C, Bruneau N, Cottet-Eymard JM, Domenech-Jouve J, Garreau B, Lelord G, Muh JP, Peyrin L (1988) Urinary free and conjugated catecholamines and metabolites in autistic children. J Autism Devel Disord 18:583\u2013591. https:\/\/doi.org\/10.1007\/BF02211876","journal-title":"J Autism Devel Disord"},{"key":"6452_CR5","doi-asserted-by":"publisher","first-page":"100834","DOI":"10.1016\/j.spen.2020.100834","volume":"35","author":"DQ Beversdorf","year":"2020","unstructured":"Beversdorf DQ (2020) The role of the noradrenergic system in autism spectrum disorders, implications for treatment. Semin Pediatr Neurol 35:100834. https:\/\/doi.org\/10.1016\/j.spen.2020.100834","journal-title":"Semin Pediatr Neurol"},{"key":"6452_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/13554790802368661","volume":"14","author":"DQ Beversdorf","year":"2008","unstructured":"Beversdorf DQ, Carpenter AL, Miller RF, Cios JS, Hillier A (2008) Effect of propranolol on verbal problem solving in autism spectrum disorder. Neurocase 14:378\u2013383. https:\/\/doi.org\/10.1080\/13554790802368661","journal-title":"Neurocase"},{"key":"6452_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/WNN.0b013e318204d20e","volume":"24","author":"DQ Beversdorf","year":"2011","unstructured":"Beversdorf DQ, Saklayen S, Higgins KF, Bodner KE, Kanne SM, Christ SE (2011) Effect of propranolol on word fluency in autism. Cogn Behav Neurol 24:11\u201317. https:\/\/doi.org\/10.1097\/WNN.0b013e318204d20e","journal-title":"Cogn Behav Neurol"},{"key":"6452_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/DBP.0000000000000351","volume":"37","author":"DQ Beversdorf","year":"2016","unstructured":"Beversdorf DQ, Wang P, Barnes G, Weisskopf M, Hardan A, Hu V, Mazurek MO, Talebizadeh Z, Goldberg W, Jones KL, Campbell DB, Feliciano P, Spence S, Muller RA, Brown RMA, Kanne SM, Sohl K, Smith DG, London E, Bauman ML, Amaral DG (2016) Phenotyping, etiological factors, and biomarkers: toward precision medicine in autism spectrum disorder. J Dev Behav Pediatr 37:659\u2013673. https:\/\/doi.org\/10.1097\/DBP.0000000000000351","journal-title":"J Dev Behav Pediatr"},{"key":"6452_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fphys.2018.00467","volume":"9","author":"L Billeci","year":"2019","unstructured":"Billeci L, Tonacci A, Narzisi A, Manigrasso Z, Varanini M, Fulceri LC, Calderoni S, Muratori F (2019) Heart rate variability during a joint attention task in toddlers with autism spectrum disorders. Front Physiol 9:467. https:\/\/doi.org\/10.3389\/fphys.2018.00467","journal-title":"Front Physiol"},{"key":"6452_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1017\/S1355617712000070","volume":"18","author":"KE Bodner","year":"2012","unstructured":"Bodner KE, Beversdorf DQ, Saklayen SS, Christ SE (2012) Noradrenergic moderation of working memory impairments in adults with autism spectrum disorder. J Intl Neuropsychol Soc 18:556\u2013564. https:\/\/doi.org\/10.1017\/S1355617712000070","journal-title":"J Intl Neuropsychol Soc"},{"key":"6452_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pbb.2007.08.003","volume":"88","author":"HL Campbell","year":"2008","unstructured":"Campbell HL, Tivarus ME, Hillier A, Beversdorf DQ (2008) Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility. Pharmacol Biochem Behav 88:222\u2013229. https:\/\/doi.org\/10.1016\/j.pbb.2007.08.003","journal-title":"Pharmacol Biochem Behav"},{"key":"6452_CR12","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1007\/s10803-006-0318-4","volume":"27","author":"AM Chalfant","year":"2007","unstructured":"Chalfant AM, Rapee R, Carroll L (2007) Rating anxiety disorders in children with high functioning autism spectrum disorders: a controlled trial. J Autism Devel Disord 27:1842\u20131857. https:\/\/doi.org\/10.1007\/s10803-006-0318-4","journal-title":"J Autism Devel Disord"},{"key":"6452_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biopsycho.2018.12.010","volume":"140","author":"BA Corbett","year":"2019","unstructured":"Corbett BA, Muscatello RA, Baldinger C (2019) Comparing stress and arousal systems in response to different social context in children with ASD. Biol Psychol 140:119\u2013130. https:\/\/doi.org\/10.1016\/j.biopsycho.2018.12.010","journal-title":"Biol Psychol"},{"key":"6452_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/000992289103000706","volume":"30","author":"HC Faigel","year":"1991","unstructured":"Faigel HC (1991) The effect of beta blockade on stress-induced cognitive dysfunction in adolescents. Clin Pediatrics 30:441\u2013445. https:\/\/doi.org\/10.1177\/000992289103000706","journal-title":"Clin Pediatrics"},{"key":"6452_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/108835760602100104","volume":"21","author":"S Farrugia","year":"2006","unstructured":"Farrugia S, Hudson J (2006) Anxiety in adolescents with Asperger syndrome: negative thoughts, behavioral problems, and life interference. Focus on Autism and Other Devel Disabil 21:25\u201335. https:\/\/doi.org\/10.1177\/108835760602100104","journal-title":"Focus on Autism and Other Devel Disabil"},{"key":"6452_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/1744629507083585","volume":"11","author":"A Gillott","year":"2007","unstructured":"Gillott A, Standen PJ (2007) Levels of anxiety and sources of stress in adults with autism. J Intellect Disabil 11:359\u2013370. https:\/\/doi.org\/10.1177\/1744629507083585","journal-title":"J Intellect Disabil"},{"key":"6452_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1362361301005003005","volume":"5","author":"A Gillott","year":"2001","unstructured":"Gillott A, Furniss F, Walter A (2001) Anxiety in high-functioning children with autism. Autism 5:277\u2013286. https:\/\/doi.org\/10.1177\/1362361301005003005","journal-title":"Autism"},{"key":"6452_CR18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10803-010-0977-z","volume":"40","author":"R Greenaway","year":"2010","unstructured":"Greenaway R, Howlin P (2010) Dysfunctional attitudes and perfectionism and their relationship to anxious and depressive symptoms in boys with autism spectrum disorders. J Autism Devel Disord 40:1179\u20131187. https:\/\/doi.org\/10.1007\/s10803-010-0977-z","journal-title":"J Autism Devel Disord"},{"key":"6452_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","volume":"71","author":"AY Hardan","year":"2012","unstructured":"Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, Frazier TW, Tirouvanziam R (2012) A randomized controlled pilot trial of oral n-acetylcysteine in children with autism. Biol Psychaitr 71:956\u2013961. https:\/\/doi.org\/10.1016\/j.biopsych.2012.01.014","journal-title":"Biol Psychaitr"},{"key":"6452_CR20","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1007\/s11682-016-9604-8","volume":"11","author":"JP Hegarty II","year":"2017","unstructured":"Hegarty JP II, Ferguson BJ, Zamzow RM, Rohowetz LJ, Johnson JD, Christ SE, Beversdorf DQ (2017) Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder. Brain Imag Behav 11:1278\u20131289. https:\/\/doi.org\/10.1007\/s11682-016-9604-8","journal-title":"Brain Imag Behav"},{"key":"6452_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.drugalcdep.2006.04.002","volume":"84","author":"KM Kampman","year":"2006","unstructured":"Kampman KM, Dackis C, Lynch KG, Pettinati H, Tirado C, Gariti P, Sparkman T, Atzram M, O\u2019Brien CP (2006) A double-blind, placebo-controlled trial of amantadine, propranolol, and their contribution for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend 84:129\u2013137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.04.002","journal-title":"Drug Alcohol Depend"},{"key":"6452_CR22","first-page":"213","volume":"49","author":"M Lader","year":"1988","unstructured":"Lader M (1988) Beta-adrenergic antagonists in neuropsychiatry: an update. J Clin Psychiatry 49:213\u2013223","journal-title":"J Clin Psychiatry"},{"key":"6452_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archpsyc.1977.01770170063005","volume":"34","author":"CR Lake","year":"1977","unstructured":"Lake CR, Ziegler MG, Murphy DL (1977) Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry 34:553\u2013556. https:\/\/doi.org\/10.1001\/archpsyc.1977.01770170063005","journal-title":"Arch Gen Psychiatry"},{"key":"6452_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF01487064","volume":"17","author":"J-M Launay","year":"1987","unstructured":"Launay J-M, Bursztejn C, Ferrari P, Dreux C, Braconnier A, Zarifian E, Lancrenon S, Fermanian J (1987) Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Devel Disord 17:333\u2013347. https:\/\/doi.org\/10.1007\/BF01487064","journal-title":"J Autism Devel Disord"},{"key":"6452_CR25","first-page":"481","volume":"17","author":"B Laverdue","year":"1991","unstructured":"Laverdue B, Boulenger JP (1991) M\u00e9dications b\u00eata-bloquantes et anxi\u00e9t\u00e9. Un int\u00e9r\u00eat th\u00e9rapeutique certain Beta-blocking drugs and anxiety. A Proven Therapeutic Value L\u2019Encephale 17:481\u2013492","journal-title":"A Proven Therapeutic Value L\u2019Encephale"},{"key":"6452_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/JCP.0000000000001175","volume":"40","author":"EB London","year":"2020","unstructured":"London EB, Yoo JH, Fethke ED, Zimmerman-Bier B (2020) The safety and effectiveness of high-dose propranolol as a treatment for challenging behaviors in individuals with autism spectrum disorders. J Clin Psychopharmacol 40:122\u2013129. https:\/\/doi.org\/10.1097\/JCP.0000000000001175","journal-title":"J Clin Psychopharmacol"},{"key":"6452_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02211841","volume":"19","author":"C Lord","year":"1989","unstructured":"Lord C, Rutter N, Goode S, Heemsbergen J (1989) Autism Diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Devel Disord 19:185\u2013212. https:\/\/doi.org\/10.1007\/BF02211841","journal-title":"J Autism Devel Disord"},{"key":"6452_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter N, LeCouteur A (1994) Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Devel Disord 24:659\u2013685. https:\/\/doi.org\/10.1007\/BF02172145","journal-title":"J Autism Devel Disord"},{"key":"6452_CR29","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","volume":"48","author":"RN Marcus","year":"2009","unstructured":"Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG (2009) A placebo-controlled, fixed dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48:1110\u20131119. https:\/\/doi.org\/10.1097\/CHI.0b013e3181b76658","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"6452_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00401-006-0061-0","volume":"111","author":"M Martchek","year":"2006","unstructured":"Martchek M, Thevarkunnel S, Bauman M, Blatt G, Kemper T (2006) Lack of evidence of neuropathology in the locus coeruleus in autism. Acta Neuropathol 111:497\u2013499. https:\/\/doi.org\/10.1007\/s00401-006-0061-0","journal-title":"Acta Neuropathol"},{"key":"6452_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1469-8749.1992.tb11490.x","volume":"34","author":"J Martineau","year":"1992","unstructured":"Martineau J, Barthelemy C, Jouve J, Muh J-P, Lelord G (1992) Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Devel Med Child Neurol 34:593\u2013603. https:\/\/doi.org\/10.1111\/j.1469-8749.1992.tb11490.x","journal-title":"Devel Med Child Neurol"},{"key":"6452_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-017-0100-y","volume":"33","author":"A Masi","year":"2017","unstructured":"Masi A, DeMayo MM, Glozier N, Guastella AJ (2017) An overview of autism spectrum disorder, heterogeneity and treatment options. Neurosci Bull 33:183\u2013193. https:\/\/doi.org\/10.1007\/s12264-017-0100-y","journal-title":"Neurosci Bull"},{"issue":"5","key":"6452_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"JT McCracken","year":"2002","unstructured":"McCracken JT, McGough J, Shah B et al (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347(5):314\u2013321. https:\/\/doi.org\/10.1056\/NEJMoa013171","journal-title":"N Engl J Med"},{"key":"6452_CR34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41386-022-01295-4","volume":"47","author":"CJ McDougle","year":"2022","unstructured":"McDougle CJ, Thom RP, Ravichandran CT, Palumbo ML, Politte LC, Mullett JE, Keary CJ, Erickson CA, Stigler KA, Methiew-Frasier L, Posey DJ (2022) A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. Neuropsychopharmacology 47:1263\u20131270. https:\/\/doi.org\/10.1038\/s41386-022-01295-4","journal-title":"Neuropsychopharmacology"},{"key":"6452_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0006-3223(94)90605-x","volume":"36","author":"RB Minderaa","year":"1994","unstructured":"Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1994) Noradrenergic and adrenergic functioning in autism. Biol Psychiatry 36:237\u2013241. https:\/\/doi.org\/10.1016\/0006-3223(94)90605-x","journal-title":"Biol Psychiatry"},{"key":"6452_CR36","doi-asserted-by":"publisher","first-page":"e1004164","DOI":"10.1371\/journal.pmed.1004164","volume":"20","author":"Y Molero","year":"2023","unstructured":"Molero Y, Kaddoura S, Kuja-Halkola R, Larsson H, Lichtenstein P, D\u2019Onofrio BM, Fazel S (2023) Associations between \u03b2-blockers and psychiatric outcomes: a population-based cohort study of 1.4 million individuals in Sweden. Plos Med 20:e1004164. https:\/\/doi.org\/10.1371\/journal.pmed.1004164","journal-title":"Plos Med"},{"key":"6452_CR37","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1542\/peds.2007-2362","volume":"120","author":"SM Myers","year":"2007","unstructured":"Myers SM, Johnson CP (2007) Management of children with autism spectrum disorders. Pediatrics 120:1162\u20131182. https:\/\/doi.org\/10.1542\/peds.2007-2362","journal-title":"Pediatrics"},{"key":"6452_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11682-010-9098-8","volume":"4","author":"A Narayanan","year":"2010","unstructured":"Narayanan A, White CA, Saklayen S, Scaduto MJ, Carpenter AL, Abduljalil A, Schmalbrock P, Beversdorf DQ (2010) Effect of propranolol on functional connectivity in autism spectrum disorder. Brain Imag Behav 4:189\u2013197. https:\/\/doi.org\/10.1007\/s11682-010-9098-8","journal-title":"Brain Imag Behav"},{"key":"6452_CR39","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L, Marcus RN, Corey-Lisle C, Manos G, McQuade RD, Carson WE, Findling RK (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124:1533\u20131540. https:\/\/doi.org\/10.1542\/peds.2008-3782","journal-title":"Pediatrics"},{"key":"6452_CR40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/BF01487073","volume":"17","author":"JJ Ratey","year":"1987","unstructured":"Ratey JJ, Bemporad J, Sorgi P, Bick P, Polakoff S, O\u2019Driscoll G, Mikkelsen E (1987) Brief report: open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults. J Autism Devel Disord 17:439\u2013446. https:\/\/doi.org\/10.1007\/BF01487073","journal-title":"J Autism Devel Disord"},{"key":"6452_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2002","unstructured":"Research Units on Pediatric Psychopharmacology Autism Network (2002) Risperidone in children with autism and serious behavioral problems. New England J Med 347:314\u2013321. https:\/\/doi.org\/10.1056\/NEJMoa013171","journal-title":"New England J Med"},{"key":"6452_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/j.1440-1614.2005.01637.x","volume":"39","author":"E Russell","year":"2005","unstructured":"Russell E, Sofronoff K (2005) Anxiety and social worries in children with Asperger syndrome. Austral New Zeal J Psychiatry 39:633\u2013638. https:\/\/doi.org\/10.1080\/j.1440-1614.2005.01637.x","journal-title":"Austral New Zeal J Psychiatry"},{"key":"6452_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0269881118756245","volume":"32","author":"I Sagar-Ouriaghli","year":"2018","unstructured":"Sagar-Ouriaghli I, Lievesley K, Santosh PJ (2018) Propranolol for treating emotional, behavioral, autonomic dysregulation in children and adolescents with autism spectrum disorder. J Psychopharmacol 32:641\u2013653. https:\/\/doi.org\/10.1177\/0269881118756245","journal-title":"J Psychopharmacol"},{"key":"6452_CR44","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","volume":"11","author":"LS Schneider","year":"1997","unstructured":"Schneider LS, Olin JT, Doody RS et al (1997) Validity and reliability of the Alzheimer\u2019s Disease Cooperative Study: clinical global impression of change. Alzheimer Dis Assoc Disord 11:S22\u2013S31. https:\/\/doi.org\/10.1097\/00002093-199700112-00004","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"6452_CR45","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","volume":"114","author":"S Shea","year":"2004","unstructured":"Shea S, Turgay A, Carroll A et al (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114(5):e634-641. https:\/\/doi.org\/10.1542\/peds.2003-0264-F","journal-title":"Pediatrics"},{"key":"6452_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biopsycho.2019.01.003","volume":"142","author":"SJ Sheinkopf","year":"2019","unstructured":"Sheinkopf SJ, Levin TP, McCormick CEB, Puggioni G, Conradt E, Lagasse LL, Lester BM (2019) Developmental trajectories of autonomic functioning in autism from birth to early childhood. Biol Psychol 142:13\u201319. https:\/\/doi.org\/10.1016\/j.biopsycho.2019.01.003","journal-title":"Biol Psychol"},{"key":"6452_CR47","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/s0005-7967(98)00034-5","volume":"36","author":"SH Spence","year":"1998","unstructured":"Spence SH (1998) A measure of anxiety symptoms among children. Behav Res Ther 36:545\u2013566. https:\/\/doi.org\/10.1016\/s0005-7967(98)00034-5","journal-title":"Behav Res Ther"},{"key":"6452_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s0887-6185(02)00236-0","volume":"17","author":"SH Spence","year":"2003","unstructured":"Spence SH, Barrett PM, Turner CM (2003) Psychometric properties of the Spence Children\u2019s Anxiety Scale with young adolescents. Anxiety Disord 17:605\u2013625. https:\/\/doi.org\/10.1016\/s0887-6185(02)00236-0","journal-title":"Anxiety Disord"},{"key":"6452_CR49","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10803-010-0959-1","volume":"40","author":"JP Stichter","year":"2010","unstructured":"Stichter JP, Herzog MJ, Visovsky K, Schmidt C, Randolph J, Schultz T, Gage N (2010) Social competence intervention for youth with Asperger syndrome and high-functioning autism: an initial investigation. J Autism Devel Disord 40:1067\u20131079. https:\/\/doi.org\/10.1007\/s10803-010-0959-1","journal-title":"J Autism Devel Disord"},{"key":"6452_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/15345084124552","volume":"38","author":"JP Stichter","year":"2012","unstructured":"Stichter JP, Herzog MJ, O\u2019Connor KV, Schmidt C (2012) A preliminary examination of a General Social Outcome Measure. Assess Eff Interv 38:40\u201352. https:\/\/doi.org\/10.1177\/15345084124552","journal-title":"Assess Eff Interv"},{"key":"6452_CR51","doi-asserted-by":"publisher","unstructured":"Wechsler D (2011) Wechsler Abbreviated Scale of Intelligence. 2nd ed. San Antonio, TX: Psychological Corporation. https:\/\/doi.org\/10.1037\/t15171-000","DOI":"10.1037\/t15171-000"},{"key":"6452_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/13803395.2014.904844","volume":"36","author":"RM Zamzow","year":"2014","unstructured":"Zamzow RM, Christ SE, Saklayen SS, Moffitt AJ, Bodner KE, Higgins KF, Beversdorf DQ (2014) Effect of propranolol on facial scanning in autism spectrum disorder: a preliminary investigation. J Clin Exp Neuropsychol 36:431\u2013445. https:\/\/doi.org\/10.1080\/13803395.2014.904844","journal-title":"J Clin Exp Neuropsychol"},{"key":"6452_CR53","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00213-015-4199-0","volume":"233","author":"RM Zamzow","year":"2016","unstructured":"Zamzow RM, Ferguson BJ, Stichter JP, Porges EC, Ragsdale AS, Lewis ML, Beversdorf DQ (2016) Effects of propranolol on conversational reciprocity in autism spectrum disroder: a pilot, double-blind, single-dose psychopharmacological challenge study. Psychopharmacol 233:1171\u20131178. https:\/\/doi.org\/10.1007\/s00213-015-4199-0","journal-title":"Psychopharmacol"},{"key":"6452_CR54","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/13803395.2016.1252724","volume":"39","author":"RM Zamzow","year":"2017","unstructured":"Zamzow RM, Ferguson BJ, Ragsdale AS, Lewis ML, Beversdorf DQ (2017) Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers. J Clin Exp Neuropsychol 39:596\u2013606. https:\/\/doi.org\/10.1080\/13803395.2016.1252724","journal-title":"J Clin Exp Neuropsychol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06452-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06452-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06452-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T06:05:26Z","timestamp":1704693926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06452-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6452"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06452-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Beversdorf serves as a consultant for YAMO Pharma, Impel Pharma, Scioto Biosciences, and Stalicla Biosciences, not related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}